Worldwide Liver Diseases Therapeutics Industrial and Market studies 2016-2019
"Global
Liver Diseases Therapeutics Market 2015-2019"
The Report covers current Market Trends, Analysis, Forecast, Review,
Share, Size, Growth, Effect.
Description-
About
liver diseases
Liver
diseases are of different types such as hepatitis, liver cancer,
non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is
the largest segment among these diseases, of which hepatitis C is the
biggest and fastest growing segment. The liver diseases caused by
viral infections, alcoholism, obesity, diabetes, among many other
reasons. Some of the diseases are not curable such as liver cirrhosis
or non-alcoholic fatty liver disease, and are usually not diagnosed
early. This leads to the substantial damage of the liver, which
proves to be life-threatening. Some types of hepatitis are
preventable or treatable by using vaccines and indicated drugs.
Technavio's
analysts forecast the global liver diseases therapeutics market to
grow at a CAGR of 15.61% over the period 2014-2019.
Covered
in this report
This
report covers the present scenario and the growth prospects of the
global liver diseases therapeutics market for 2015-2019. To calculate
the market size, the report considers revenue generated from the
sales of various off-label and branded drugs and the expected launch
of drug candidates intended to be used in the treatment of liver
diseases.
Based
on disease indication, the market is segmented as follows:
Non-alcoholic
fatty liver disease (includes non-alcoholic steatohepatitis)
Liver
cirrhosis
Liver
cancer
Hepatitis
(Hepatitis A, B, and C)
This
report includes a discussion of the market in the following three
regions:
Americas:
The major countries focused in the Americas are the US, Canada,
Mexico, and Brazil
EMEA:
The major countries in this region are the UK, Germany, Italy,
France, Spain and Middle Eastern and African countries such as
Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and
the UAE
APAC:
The major countries in this region are Japan, China, Australia,
Singapore, South Korea, and India.
Technavio's
report, Global Liver Diseases Therapeutics Market 2015-2019, has been
prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the landscape of the global liver
diseases therapeutics market and its growth prospects in the coming
years. The report includes a discussion of the key vendors operating
in this market.
Key
regions
Americas
APAC
EMEA
Key
vendors
F.
Hoffmann-La Roche
Gilead
Sciences
GlaxoSmithKline
Johnson
& Johnson
….....
…..
…...
….
Comments
Post a Comment